Duchenne muscular dystrophy (DMD) is caused by mutations in the gene that encodes the 427-kDa cytoskeletal protein dystrophin. Increased knowledge of the function of dystrophin and its role in muscle has led to a greater understanding of the pathogenesis of DMD. This, together with advances in the genetic toolkit of the molecular biologist, are leading to many different approaches to treatment. Gene therapy can be achieved using plasmids or viruses, mutations can be corrected using chimaerapl...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record